School of Pharmacy - News

Researchers at the University of Eastern Finland have developed a new and promising drug compound for the treatment of cancer that inhibits natural amino acids from entering cancer cells.

Chemical risk assessment is one of the areas where toxicology expertise is needed.

In her doctoral thesis, Paulina Jakubiak studied the binding of drugs to natural ocular pigment, melanin, as a novel approach to achieve sustained drug delivery to the back of the eye.